Table 4 Adverse Events recorded in patients during axitinib treatment
From: Axitinib as a third or further line of treatment in renal cancer: a single institution experience
Adverse Event | Any Grade N(%) | Grade >=3 N(%) |
|---|---|---|
Hypertension | 5 (22,72) | 3 (13,63) |
Arthralgia | 2 (9,09) | 1 (4,54) |
Fatigue | 11 (50) | 1 (4,54) |
Hypothyreoidism | 5 (22,72) | 0 (0) |
Increased Liver Function Tests | 3 (13,63) | 1 (4,54) |
Diarrhea | 3 (13,63) | 0 (0) |
Hand Foot Syndrom | 4 (18,18) | 4 (18,18) |
Anorexia | 1 (4,54) | 1 (4,54) |
Mucositis | 2 (9,09) | 1 (4,54) |
Muscle paitn | 1 (4,54) | 1 (4,54) |
Hoarseness | 4 (18,18) | 1 (4,54) |
Proteinurua | 2 (9,09) | 0 (0) |
Anemia | 2 (9,09) | 0 (0) |